期刊文献+

RP-HPLC测定琥珀酸美托洛尔缓释片的含量及有关物质 被引量:1

RP- HPLC determination of metoprolol succinate sustained- release tablets and its related substances
下载PDF
导出
摘要 目的建立琥珀酸美托洛尔缓释片含量及有关物质的RP-HPLC方法。方法以十八烷基硅烷键合硅胶作为填充剂ZORBAX SB-C18(4.6 mm×250 mm,5μm),以乙酸铵缓冲液(3.9 g的乙酸铵溶解于810 m L的水中,加入10.0 m L的冰乙酸,2.0 m L的三乙胺,3.0 m L的磷酸)—乙腈=82∶18,流速1.0 m L·min-1,检测波长275 nm,进样量10μL。结果琥珀酸美托洛尔在20.00~120.02 mg·L-1浓度范围内线性关系良好,检测限为0.4 ng,定量限为1.2 ng,回收率为100.75%(RSD=0.67%),测定样品含量为99.8%,有关物质均小于0.2%。结论该方法快速,简单,稳定,重现性好,可作为琥珀酸美托洛尔缓释片的含量及有关物质的检测方法。 Objective To establish an RP- HPLC method for determination of the content of metoprolol succinate sustained- release tablets and its related substances. Methods The chromatographic separation was performed on ZORBAX SB- C18( 4. 6 mm × 250 mm,5 μm) that was made by alkyl- bonded silica gels,ammonium acetate buffer solution( 3. 9 g acetic ammonia dissolved in 810 m L water,with an addition of 10. 0 m L acetic acid,2. 0 m L triethylamine,3. 0 m L phosphoric acid)- acetonitrile = 82 ∶ 18. The flow rate was 1. 0 m L·min- 1. The detection wavelength was 275 nm. The sample size was 10 μL. Results There is good linearity within the range of 20. 00 ~ 120. 02 mg·L- 1. The detection limit was 0. 4 ng. The limit of quantitation was 1. 2 ng. The average recovery was 100. 75%( RSD = 0. 67%). Determination of the sample average content was 99. 8%,and the related substance was less than 0.2%. Conclusion The method is quick,simple,stable and repeatable,which could be used to determine the content of metoprolol succinate sustained- release tablets and its related substances.
出处 《安徽医药》 CAS 2015年第12期2306-2309,共4页 Anhui Medical and Pharmaceutical Journal
关键词 琥珀酸美托洛尔 HPLC法 含量 有关物质 metoprolol succinate sustained-release tablet HPLC content related substance
  • 相关文献

参考文献5

二级参考文献44

  • 1赵丽丽,罗勇.阿托伐他汀在高血压病治疗中的研究进展[J].中华临床医师杂志(电子版),2011,5(9):2672-2674. 被引量:13
  • 2吴学思.正确掌握β受体阻滞剂在慢性心力衰竭的应用时机[J].中华心血管病杂志,2006,34(9):769-771. 被引量:62
  • 3李为民,刘巍.2005年中国高血压防治指南评介[J].中国实用内科杂志,2007,27(12):899-902. 被引量:73
  • 4陆再英,钟南山内科学[M].7版.北京:人民卫生出版社,2008:614.
  • 5李端.药理学[M].北京:人民卫生出版社,2006.
  • 6中华医学会心血管病学分会.β受体阻滞剂在心血管疾病应用的专家共识.
  • 7Fisher AA, Davis M, Jeffery I. Acute delirium induced by metoproloI[J]. Cardiovasc Drugs Ther, 2002,16 : 161-165.
  • 8Ahmed AI, van Mierlo P. Sleep disorders, nightmares, depres- sion and anxiety in an elderly patient treated with low-dose metoprolol[J]. Gen Hosp Psychiatry,2010,32 (6):646. e5 - e7.
  • 9Conant J,Engler R,Janowsky D,etal. Central nervous system side effects of beta-adrenergic blocking agents with high and low lipid solubility[J]. J Cardiovasc Pharmacol, 1989, 13: 656- 661.
  • 10McAinsh J,Cruickshank JM. Beta-blockers and central nervous system side effects[J]. Pharmacol Ther, 1990,46 (2) : 163-197.

共引文献22

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部